Although some patients would benefit from automatic functions of the most advanced pumps that suspend the insulin delivery, or work in hybrid mode, enabling them to reduce their hypoglycemia incidents and correcting their mistakes in bolusing, there are other patients for whom this system could be rather burdensome. The gene discussed is INS; the disease is Hypoglycemia.